Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Am J Med Genet A. 2023 Aug;191(8):2149-2155. doi: 10.1002/ajmg.a.63302. Epub 2023 May 22.
SRRM2-related neurodevelopmental disorder is a recently described genetic diagnosis caused by loss-of-function variants in SRRM2. In order to understand the clinical spectrum of SRRM2-related neurodevelopmental disorder, we performed a retrospective exome data and clinical chart review at a single tertiary children's hospital, Children's Hospital of Philadelphia (CHOP). Among approximately 3100 clinical exome sequencing cases performed at CHOP, we identified three patients with SRRM2 loss-of-function pathogenic variants, in addition to one patient previously described in the literature. Common clinical features include developmental delay, attention deficit hyperactivity disorder, macrocephaly, hypotonia, gastroesophageal reflux, overweight/obesity, and autism. While developmental disabilities are commonly seen in all individuals with SRRM2 variants, the degree of developmental delay and intellectual disability is variable. Our data suggest that SRRM2-related neurodevelopmental disorder can be identified in 0.3% of individuals with developmental disabilities receiving exome sequencing.
SRRM2 相关神经发育障碍是一种新描述的遗传诊断,由 SRRM2 中的功能丧失变异引起。为了了解 SRRM2 相关神经发育障碍的临床谱,我们在费城儿童医院(CHOP)的一家单一的三级儿童医院进行了回顾性外显子组数据和临床图表审查。在 CHOP 进行的大约 3100 例临床外显子组测序病例中,我们除了在文献中描述的一名患者外,还发现了三名患有 SRRM2 功能丧失致病性变异的患者。常见的临床特征包括发育迟缓、注意缺陷多动障碍、大头畸形、肌张力低下、胃食管反流、超重/肥胖和自闭症。虽然所有携带 SRRM2 变异的个体通常都存在发育障碍,但发育迟缓的程度和智力障碍的程度是可变的。我们的数据表明,在外显子组测序的发育障碍患者中,0.3%可识别出 SRRM2 相关神经发育障碍。